Director, Medical Communications (Oncology/Hematology)
- Employer
- Regeneron Pharmaceuticals, Inc.
- Location
- Sleepy Hollow, New York
- Start date
- Sep 3, 2023
View more
- Discipline
- Marketing, Marketing/Corporate Communications, Science/R&D, Oncology
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Pharm Country, Best Places to Work
Job Details
As a Director, Scientific Communications you will play a pivotal role in leading and aligning strategic, integrated medical communications efforts for Oncology and Hematology. This will include our Congress strategy/plans in partnership with the Oncology and Hematology Medical Directors. You will develop our global scientific communication platforms, which will serve as the foundational resources for cross-harmonizing and delivering evidence-based communications. We are expected to ensure content is accurate, concise and accessible while driving and creating meaningful communications tailored to diverse audience needs. Our goal is to galvanize engagement, advance medical knowledge, and ultimately improve clinical care for patients.
This entails collaboration and partnership with colleagues in Medical Affairs, patient advocacy, clinical development, corporate communications, commercial, and access & reimbursement.
Please note: This position will require you to be on-site 3 days/week located at our Sleepy Hollow, NY office. A fully remote option is not available.
A typical day may include the following:
Lead the development and alignment of a comprehensive Integrated Medical Communication Plan(s)
Establish and effectively communicate clear Scientific Communication objectives and goals to internal partners, and formulate a tactical plan for compliant execution
Partner with Medical Directors and collaborators devising an overarching Congress strategy and align on Congress presence and projects
Drive the creation and development of Scientific Communications materials with a focus on Scientific Communication Platform and Lexicon
Assess medical education gaps and needs of external partners
Address knowledge gaps, or Clinical Impact Opportunities, with tailored, targeted and timely content creation which can be adapted for engagement across regions
Ensure medical and scientific integrity and accuracy of created content and ensure materials have a fair and balanced representation
Work with Project Manager to supervise all materials are delivered within the allocated budget, and tracks budget spend in a systematic manner
This may be for you if you:
Want to impact the strategic globalization of our Scientific/Medical Communication plans.
Are motivated by the impact of your work on patient health.
Can demonstrate a highly developed scientific and the ability to effectively communicate sophisticated scientific concepts.
Have the enthusiasm for driving innovative and impactful scientific communications to optimize engagement and advance medical knowledge
Can lead and collaborate in a cross-functional and culturally diverse environment
To be considered you are to have a doctorate level education (PhD, MD, or PharmD) with Scientific Communication experience and expertise in Oncology/Hematology-Oncology. Minimum of 8 years of progressing responsibility in the pharmaceutical industry or Medical Communication agency, including > 4 years in Scientific Communications and Medical Affairs.
Travel to relevant industry conferences is expected.
Additional experiences should include:
In-depth understanding of medical communication strategies, congress strategies, scientific content development and medical education
Ability to develop and align medical communications strategies with broader business goals
Assessing data/metrics/information to inform decision-making
Ability to provide informed and meaningful insight into scientific communication planning and expert engagement activities
Salary Range (annually)
$172,500.00 - $287,500.00Company
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
Stock Symbol: REGN
Stock Exchange: NASDAQ
- Website
- https://www.regeneron.com/
- Phone
- 914-847-7000
- Location
-
Corporate Headquarters
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert